Pharmacy Drugs
Recent Posts
- Malignant Brain Tumors: Chemotherapy Alone Is Just As Effective As Radiation / New Positive Prognostic Factor Found
- Positive Interim Data From Minnow Medical Peripheral Artery Disease Trial Presented At TCT 2009 Conference
- Intercept Pharmaceuticals’ FXR Agonist INT-747 Meets Primary Endpoint In A Phase II Clinical Trial In Type 2 Diabetic Patients
- Largest Clinical Trial To Test Benefits Of Aspirin In Australia
- University Of Florida To Receive $29.5 Million In Recovery Act Funds To Begin Study Of Whether Exercise Prevents Disability In Older Adults
Random Posts
- Traits Of People With Rare Accelerated Aging Syndrome Identified By Researchers
- Rapid-Acting Insulin Analogues: Trials Provide No Proof Of Additional Benefit For Children And Adolescents With Type 1 Diabetes
- Efforts To Quickly Develop Swine Flu Vaccine Reported In GEN
- Re-Identification Of Patients: New Study Looks At The Risks
- Wearable Kidney May Replace Dialysis Machine
- Breast Cancer Survival Improves Herceptin Used With Chemotherapy
- Bortezomib Shows Promise In Reducing GVHD And Reconstituting Immune System In Some Patients
- FDA Gives Nod to First Generic Oral Disintegrating Alzheimer's Medication
- Synergy Pharmaceuticals To Present Phase I Volunteer Study On SP-304 Investigational Drug To Treat GastroIntestinal Disorders At Upcoming Conference
- Popular Antidepressant Associated With A Dramatic Increase In Suicidal Thoughts Amongst Men
Pharmacists’ Association Executive To Receive The Food And Drug Administration’s Commissioner’s Special Citation Award
Posted by: admin in Pharmacy Drugs on October 07th, 2009
John A. Gans, PharmD, Executive Vice President and Chief Executive Officer for the American Pharmacists Association (APhA) has been selected as a recipient of the gov/” rel=”nofollow”>Food and Drug Administration ’s (FDA) Commissioner’s Special Citation Award. The award will be bestowed upon Dr. Gans today during a ceremony at Martin’s Crosswinds, Greenbelt, Maryland.
The award is being presented to Dr. Gans in recognition of 20 years of outstanding leadership in ensuring issues of importance to pharmacists and the APhA are considered in FDA regulatory decision-making.
In congratulating Gans, Dr. Joshua Sharfstein, Acting Commissioner of Food and Drugs, Principal Deputy Commissioner said, “You have been chosen for this award because you have provided invaluable assistance to the FDA. To be selected for special recognition should be most satisfying since accomplishments such as yours impact the well being of the public.”
Dr. Gans has been APhA’s Executive Vice President and Chief Executive Officer since 1989, focusing on positioning pharmacists as valued members of the healthcare team who can improve medication use and advance patient care. Prior to joining APhA Gans served on the faculty and was Dean of the School of Pharmacy at the Philadelphia College of Pharmacy and Science (now known as the University of the Sciences in Philadelphia), where he earned his pharmacy degree in l966 and his doctorate in pharmacy in 1969.
Dr. Gans began his career in 1966 as a community pharmacist in Broomall, Pennsylvania. During 1967-68, Dr. Gans held a residency at the Hospital of the University of Pennsylvania. Following his residency, he became Assistant Director of Pharmacy at the Hospital of the University of Pennsylvania and held that position from 1968-70. He was a pioneer in the area of parenteral nutrition and clinical pharmacy. From 1974 to 1985, he served as the Managing Director of Pharmaservices, a consultant firm to nursing homes.
Dr. Gans has served as the Founding Chairman of the Delaware Valley Regional Poison Control Program, which established a 24-hour regional poison control center in 1985. In 1980-81, he served as President of the Pennsylvania Society of Hospital Pharmacists and, in 1986-87, as President of the American Society of Hospital Pharmacists.
Dr. Gans will step down in July as EVP and CEO of APhA after nearly 20 years of service to the organization.
Source
American Pharmacists Association (APhA)
No Comments »
No comments yet.
RSS feed for comments on this post. TrackBack URL
Leave a comment
You must be logged in to post a comment.